SCHEMBL5198091

SCHEMBL5198091

Cc1cc(C)c(C2CNC(=C3CCCCC3P(C3CCCCC3)C3CCCCC3)N2c2c(C)cc(C)cc2C)c(C)c1.Cl[Ru]Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14974857 0.86
SCHEMBL246487 0.85
SCHEMBL17047975 0.85
SCHEMBL5072342 0.82
SCHEMBL14881263 0.82
SCHEMBL14881085 0.78
SCHEMBL29489277 0.69 TAS1R3 (0.31)
Hydrochloric Acid SCHEMBL935838 0.69
SCHEMBL30239293 0.69 TAS1R3 (0.30)
SCHEMBL29598254 0.63 HPGD (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1814893-A2 NOVEL LINCOMYCIN DERIVATIVES POSSESSING ANTIBACTERIAL ACTIVITY Vicuron Pharmaceuticals, Inc. (US) 2007-08-08 EP disclosed
WO-2006055070-A2 NOVEL LINCOMYCIN DERIVATIVES POSSESSING ANTIBACTERIAL ACTIVITY VICURON PHARMACEUTICALS INC. (US) 2006-05-26 WO disclosed